Delivery of chlorambucil using an acoustically-triggered perfluoropentane emulsion

Ultrasound in Medicine and Biology

Volumn 36, Issue 8, 2010, Pages 1364-1375

  Fabiilli, Mario L ^a,b   Haworth, Kevin J ^a,b   Sebastian, Ian E ^b   Kripfgans, Oliver D ^a,b   Carson, Paul L ^a,b   Fowlkes, J Brian ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Acoustic droplet vaporization; Chemotherapy; Chlorambucil; Droplets; Drug delivery; Emulsion; Perfluorocarbon; Superheated; Ultrasound

Indexed keywords

ACOUSTIC DROPLET VAPORIZATION; CELLULAR GROWTH; CHLORAMBUCIL; DELIVERY SYSTEMS; DROPLET DIAMETERS; GAS BUBBLE; GENETIC MATERIALS; GROWTH INHIBITION; MICROBUBBLE CONTRAST AGENTS; PERFLUOROCARBONS; SOYBEAN OIL; SUPERHEATED EMULSIONS; ULTRASOUND EXPOSURE;

CHEMOTHERAPY; DRUG DELIVERY; EMULSIFICATION; ULTRASONIC TRANSMISSION; ULTRASONICS; VAPORIZATION;

DROP FORMATION;

ALBUMIN; CHLORAMBUCIL; PERFLUOROPENTANE; SOYBEAN OIL;

ACOUSTIC DROPLET VAPORIZATION; ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG CYTOTOXICITY; EMULSION; ENCAPSULATION; GAS BUBBLE; GROWTH INHIBITION; MATERIAL STATE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; THERMAL EXPOSURE; ULTRASOUND; VAPORIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CELL SURVIVAL; CHLORAMBUCIL; CHO CELLS; CRICETINAE; CRICETULUS; DRUG DELIVERY SYSTEMS; EMULSIONS; FLUOROCARBONS; SONICATION;

EID: 77955403127     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2010.04.019     Document Type: Article

References (50)

1. Apfel R.E. Activatable infusable dispersions containing drops of a superheated liquid for methods of therapy and diagnosis 1998, Patent 5,840,276, Apfel Enterprises, Inc.
2. Borden M.A., Caskey C.F., Little E., Gillies R.J., Ferrara K.W. DNA and polylysine adsorption and multilayer construction onto cationic lipid-coated microbubbles. Langmuir 2007, 23:9401-9408.
3. Bucala R., Kawakami M., Cerami A. Cytotoxicity of a perfluorocarbon blood substitute to macrophages in vitro. Science 1983, 220:965-967.
4. Centis V., Doillon C.J., Vermette P. Perfluorocarbon emulsions cytotoxic effects on human fibroblasts and effect of aging on particle size distribution. Artif Organs 2007, 31:649-653.
5. Dalecki D. Mechanical bioeffects of ultrasound. Annu Rev Biomed Eng 2004, 6:229-248.
6. Detke S., Stein J.L., Stein G.S. Influence of chlorambucil, a bifunctional alklyating agent, on DNA replication and histone gene expression in HeLa S-3 cells. Cancer Res 1980, 40:967-974.
7. Eisenbrey J., Huang P., Hsu J., Wheatley M. Ultrasound triggered cell death in vitro with doxorubicin loaded poly lactic-acid contrast agents. Ultrasonics 2009, 49:628-633.
8. Fabiilli M.L., Haworth K.J., Fakhri N.H., Kripfgans O.D., Carson P.L., Fowlkes J.B. The role of inertial cavitation in acoustic droplet vaporization. IEEE Trans Ultrason Ferroelectr Freq Control 2009, 56:1006-1017.
9. Fang J.Y., Hung C.F., Hua S.C., Hwang T.L. Acoustically active pefluorocarbon nanoemulsions as drug delivery carriers for camptothecin: Drug release and cytoxicity against cancer cells. Ultrasonics 2009, 49:39-46.
10. Fang J.Y., Hung C.F., Liao M.H., Chien C.C. A study of the formulation design of acoustically active lipospheres as carriers for drug delivery. Eur J Pharm Biopharm 2007, 67:67-75.
11. Freshney R.I. Culture of animal cells-a manual of basic technique 2005, John Wiley & Sons, Inc., Hoboken (NJ). 5th ed.
12. Ganta S., Devalapally H., Baguley B.C., Garg S., Amiji M. Microfluidic preparation of chlorambucil nanoemulsion formulations and evaluation of cytotoxicity and pro-apoptotic activity in tumor cells. J Biomed Nanotechnology 2008, 4:165-173.
13. Ganta S., Paxton J.W., Baguley B.C., Garg S. Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion. Int J Pharm 2008, 360:115-121.
14. Goubault C., Pays K., Olea D., Gorria P., Bibette J., Schmitt V., Leal-Calderon F. Shear rupturing of complex fluids: Application to the preparation of quasi-monodisperse water-in-oil-in-water double emulsions. Langmuir 2001, 17:5184-5188.
15. Haworth K.J., Kripfgans O.D. Initial growth and coalescence of acoustically vaporized perfluorocarbon microdroplets. IEEE Int Ultrason Symp Proc 2008, 623-626.
16. Hernot S., Klibanov A.L. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 2008, 60:1153-1166.
17. Hussain-Hakimjee E.A., Peng X., Mehta R.R., Mehta R.G. Growth inhibition of carcinogen- transformed MCF-12F breast epithelial cells and hormone-sensitive BT-474 breast cancer cells by 1 alpha- hydroxyvitamin D5. Carcinogenesis 2006, 27:551-559.
18. Hwang T.L., Lin Y.J., Chi C.H., Huang T.H., Fang J.Y. Development and evaluation of perfluorocarbon nanobubbles for apomorphine delivery. J Pharm Sci 2009, 98:3735-3747.
19. Johnson J.L.H., Dolezal M.C., Kerschen A., Matsunaga T.O., Unger E.C. In vitro comparison of dodecafluoropentane (DDFP), perfluorodecalin (PFD), and perfluoroctylbromide (PFOB) in the facilitation of oxygen exchange. Artif Cells Blood Substit Immobil Biotechnol 2009, 37:156-162.
20. Kawabata K., Sugita N., Yoshikawa H., Azuma T., Umemura S. Nanoparticles with multiple perfluorocarbons for controllable ultrasonically induced phase shifting. Jpn J Appl Phys 2005, 44:4548-4552.
21. Kheirolomoom A., Dayton P.A., Lum A.F., Little E., Paoli E.E., Zheng H., Ferrara K.W. Acoustically-active microbubbles conjugated to liposomes: Characterization of a proposed drug delivery vehicle. J Control Release 2007, 118:275-284.
22. Kooiman K., Bohmer M.R., Emmer M., Vos H.J., Chlon C., Shi W.T., Hall C.S., de Winter S.H.P.M., Schroen K., Versluis M., de Jong N., van Wamel A. Oil-filled polymeric microcapsules for ultrasound-mediated delivery of lipophilic drugs. J Control Release 2009, 133:109-118.
23. Kopechek J.A., Abruzzo T.M., Wang B., Chrzanowski S.M., Smith D.A., Kee P.H., Huang S., Collier J.H., McPherson D.D., Holland C.K. Ultrasound-mediated release of hydrophilic and lipophilic agents from echogenic liposomes. J Ultrasound Med 2008, 27:1597-1606.
24. Kripfgans O.D., Fowlkes J.B., Miller D.L., Eldevik O.P., Carson P.L. Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultrasound Med Biol 2000, 26:1177-1189.
25. Kripfgans O.D., Fowlkes J.B., Woydt M., Eldevik O.P., Carson P.L. In vivo droplet vaporization for occlusion therapy and phase aberration correction. IEEE Trans Ultrason Ferroelectr Freq Control 2002, 49:726-738.
26. Kripfgans O.D., Fabiilli M.L., Carson P.L., Fowlkes J.B. On the acoustic vaporization of micrometer-sized droplets. J Acoust Soc Am 2004, 116:272-281.
27. Kripfgans O.D., Orifici C.M., Carson P.L., Ives K.A., Eldevik O.P., Fowlkes J.B. Acoustic droplet vaporization for temporal and spatial control of tissue occlusion: A kidney study. IEEE Trans Ultrason Ferroelectr Freq Control 2005, 52:1101-1110.
28. Lanza G.M., Wickline S.A. Targeted ultrasonic contrast agents for molecular imaging and therapy. Prog Cardiovasc Dis 2001, 44:13-31.
29. Lee D.H., Goh Y.M., Kim J.S., Kim H.K., Kang H.H., Suh K.D., Kim J.W. Effective formation of silicone-in-fluorocarbon-in-water double emulsions: Studies on droplet morphology and stability. J Dispers Sci Technol 2002, 23:491-497.
30. Lentacker I., De Geest B.G., Vandenroucke R.E., Peeters L., Demeester J., De Smedt S.C., Sanders N.N. Ultrasound-responsive polymer-coated microbubbles that bind and protect DNA. Langmuir 2006, 22:7273-7278.
31. Lin A.A., Miller W.M. CHO cell responses to low oxygen: Regulation of oxygen consumption and sensitization to oxidative stress. Biotechnol Bioeng 1992, 40:505-516.
32. Lopes N.M., Adams E.G., Pitts T.W., Bhuyan B.K. Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemother Pharmacol 1993, 32:235-242.
33. Lowe K.C., Davey M.R., Power J.B. Perfluorochemicals: Their applications and benefits to cell culture. Trends Biotechnol 1998, 16:272-277.
34. May D.J., Allen J.S., Ferrara K.W. Dynamics and fragmentation of thick-shelled microbubbles. IEEE Trans Ultrason Ferroelectr Freq Control 2002, 49:1400-1410.
35. McKeown S., Cowen R., Williams K. Bioreductive drugs: From concept to clinic. Clin Oncol 2007, 19:427-442.
36. Perry M.C. The Chemotherapy Source Book 2008, Lippincott Williams & Wilkins, Philadelphia. 4th ed.
37. Price P., Sikora K. Treatment of Cancer 2002, Oxford University Press, New York. 4th ed.
38. Priestman T. Cancer chemotherapy in clinical practive 2008, Spinger-Verlag, London.
39. Pua E.C., Zhong P. Ultrasound-mediated drug delivery. IEEE Eng Med Biol Mag 2009, 28:64-75.
40. Rapoport N., Gao Z., Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 2007, 99:1095-1106.
41. Rapoport N.Y., Kennedy A.M., Shea J.E., Scaife C.L., Nam K.H. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J Control Release 2009, 138:268-276.
42. Riess J.G. Oxygen carriers (″ blood substitutes″ )-Raison d'etre, chemistry, and some physiology. Chem Rev 2001, 101:2797-2919.
43. Ross D.W. The nature of unbalanced cell growth caused by cytotoxic agents. Virchow Arch B - Cell Pathol 1981, 37:225-235.
44. Shenoy V., Vijay I., Murthy R. Tumour targeting: biological factors and formulation advances in injectable lipid nanoparticles. J Pharm Pharmacol 2005, 57:411-421.
45. Sonntag N. Surfactants in herbicide dispersions. Surfactants in chemical/process engineering 1988, vol. 28. Marcel Dekker, Inc., New York. D.T. Wasan, M.E. Ginn, D.O. Shah (Eds.).
46. Tartis M.S., McCallan J., Lum A.F., LaBell R., Stieger S.M., Matsunaga T.O., Ferrara K.W. Therapeutic effects of paclitaxel-containing ultrasound contrast agents. Ultrasound Med Biol 2006, 32:1771-1780.
47. Tinkov S., Bekeredjian R., Winter G., Coester C. Microbubbles as ultrasound triggered drug carriers. J Pharm Sci 2009, 98:1935-1961.
48. Unger E., McCreery T., Sweitzer R., Caldwell V., Wu Y. Acoustically active lipospheres containing paclitaxel-A new therapeutic contrast agent. Invest Radiol 1998, 33:886-892.
49. Unger E.C., Porter T., Culp W., LaBell R., Matsunaga T., Zutshi R. Therapeutic applications of lipid-coated microbubbles. Adv Drug Deliv Rev 2004, 56:1291-1314.
50. Yamazaki Y., Kunimoto S., Ikeda D. Rakicidin a: a hypoxia-selective cytotoxin. Biol Pharm Bull 2007, 30:261-265.